Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes

Fig. 1

Design of PFS. Figure was repurposed from Ayman R. Kafal, Donald C. Vinh & Mélanie J. Langelier [31] Prefilled syringes for immunoglobulin G (IgG) replacement therapy: clinical experience from other disease settings, Expert Opinion on Drug Delivery, 15:12, 1199-1209, https://doi.org/10.1080/17425247.2018.1546692 and is covered by the Creative Commons Attribution-NonCommercial-NoDerivatives License. PFS, pre-filled syringes

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us